secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTUATE THERAPEUTICS, INC. (ACTU)
CIK:        0001652935
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001683168-25-004766
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Actuate Therapeutics raises ~$4.7M in private placement of common stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds of approx. $4.7M from sale of 666,497 shares at $7.00/share and warrants to purchase 666,497 shares.
- Warrants exercisable at $7.00 for 20 days after Milestone Date (FDA Breakthrough Therapy or registration determination for elraglusib).
- Bios 2024 Co-Invest, LP (affiliated with Chairman Dr. Aaron G.L. Fletcher) purchasing 71,428 shares and warrants for ~$500K.
- Closing expected on or before June 30, 2025; proceeds for working capital and general corporate purposes.
- Registration rights agreement requires filing resale registration statement by August 9, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825004766/0001683168-25-004766-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825004766/actuate_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-004766

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer